Exact Mass: 512.1835
Exact Mass Matches: 512.1835
Found 500 metabolites which its exact mass value is equals to given mass value 512.1835
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physalin M
Physalin M belongs to the class of organic compounds known as physalins and derivatives. These are steroidal constituents of Physalis plants which possess an unusual 13,14-seco-16,24-cyclo-steroidal ring skeleton (where the bond that is normally present between the 13 and 14 positions in other steroids is broken while a new bond between positions 16 and 24 is formed). Physalin M is an extremely weak basic (essentially neutral) compound (based on its pKa). Physalin M is found in fruits. Physalin M is a constituent of Physalis alkekengi (winter cherry). Constituent of Physalis alkekengi (winter cherry). Physalin M is found in fruits.
O-Benzylfluorescein benzyl ester
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
(2S)-2-[[4-[(2,4-Diaminopteridin-6-yl)methyl]-2,3-dihydro-1,4-benzothiazine-7-carbonyl]amino]hexanedioic acid
sialosyl-Tn saccharide
Alvaradoin H
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone
(1R*,2S*,4S*,4S*,6S*,7R*,8R*,9S*,10S*,11Z,14S*,17S*)-14-acetoxy-6-chloro-4,8-epoxy-9,17-dihydroxy-2-propionyloxybriara-5(16),11-dien-18-one
6-(2,6-dihydroxy-4-methoxy-3-methyl-benzhydryl)-5,7-dihydroxy-8-methyl-2-phenyl-chroman-4-one|isomelanervin
1,2alpha-dehydro-3beta,4beta-dioxolan-daphnetoxin-21-one|genkwanin I
(2RS,3RS)-2,3,4,5-tetrahydro-3-(3-hydroxy-5-methoxyphenyl)-2-(4-hydroxy-3-methoxyphenyl)-10-methoxyphenanthro[2,1-b]furan-7-ol|phochinenin F
naphthalene-1,8-diol 1,8-bis(4-O-methyl-beta-glucopyranoside)|naphthalene-1,8-diyl bis(4-O-methyl-beta-glucopyranoside)
1beta,9alpha-di(3-furanoyloxy)-8beta-acetoxy-2-oxo-3-enedihydro-beta-agarofuran
2,2-dimethyl-2H-(8-hydroxy-6-acetyl)-[2,3-b]-pyran-8-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
3-chloro-10a-(3-chloro-6-hydroxy-2,2,6-trimethylcyclohexylmethyl)-6,8-dihydroxy-2,2,7-trimethyl-3,4,4a,10a-tetrahydro-2H-benzo[g]chromene-5,10-dione
4-{[4-hydroxy-4-hydroxymethyl-3-(4-hydroxyphenyl)ethynylbiphenyl-2-yl]-(4-hydroxyphenyl)methylene}-2,5-cyclohexadien-1-one|selaginellin
11-oxo-7alpha-obacunyl acetate|11-Oxo-7??-obacunyl acetate
Ser Tyr Asp Glu
Glu Ser Tyr Asp
Ser Tyr Glu Asp
Loperamide hydrochloride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist[1][2][3]. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect[4].
C24H32O12_Cyclopenta[c]pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,6-dihydroxy-7-methyl-, 2-(4-hydroxyphenyl)ethyl ester
C26H28N2O9_14H-Pyrano[3,4:6,7]indolizino[1,2-b]quinoline-11,14(3H)-dione, 4-ethenyl-3-(beta-D-glucopyranosyloxy)-4,4a,5,5a,6,12-hexahydro-, (3S,4R,4aS,5aS)
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_major
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_49.7\\%
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_88.5\\%
1-[2-[3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxyprop-1-en-2-yl]-2,3-dihydro-1-benzofuran-5-yl]ethanone_47.5\\%
Ala Glu Met Tyr
Ala Glu Tyr Met
Ala Met Glu Tyr
Ala Met Tyr Glu
Ala Tyr Glu Met
Ala Tyr Met Glu
Cys Asp Glu Phe
Cys Asp Phe Glu
Cys Asp Ile Tyr
Cys Asp Leu Tyr
Cys Asp Tyr Ile
Cys Asp Tyr Leu
Cys Glu Asp Phe
Cys Glu Phe Asp
Cys Glu Val Tyr
Cys Glu Tyr Val
Cys Phe Asp Glu
Cys Phe Glu Asp
Cys Ile Asp Tyr
Cys Ile Tyr Asp
Cys Leu Asp Tyr
Cys Leu Tyr Asp
Cys Met Pro Tyr
Cys Met Tyr Pro
Cys Asn Asn Tyr
Cys Asn Tyr Asn
Cys Pro Met Tyr
Cys Pro Tyr Met
Cys Val Glu Tyr
Cys Val Tyr Glu
Cys Tyr Asp Ile
Cys Tyr Asp Leu
Cys Tyr Glu Val
Cys Tyr Ile Asp
Cys Tyr Leu Asp
Cys Tyr Met Pro
Cys Tyr Asn Asn
Cys Tyr Pro Met
Cys Tyr Val Glu
Asp Cys Glu Phe
Asp Cys Phe Glu
Asp Cys Ile Tyr
Asp Cys Leu Tyr
Asp Cys Tyr Ile
Asp Cys Tyr Leu
Asp Asp Thr Tyr
Asp Asp Tyr Thr
Asp Glu Cys Phe
Asp Glu Phe Cys
Asp Glu Ser Tyr
Asp Glu Tyr Ser
Asp Phe Cys Glu
Asp Phe Glu Cys
Asp Phe Met Thr
Asp Phe Thr Met
Asp His Asn Gln
Asp His Gln Asn
Asp Ile Cys Tyr
Asp Ile Tyr Cys
Asp Leu Cys Tyr
Asp Leu Tyr Cys
Asp Met Phe Thr
Asp Met Thr Phe
Asp Asn His Gln
Asp Asn Gln His
Asp Gln His Asn
Asp Gln Asn His
Asp Ser Glu Tyr
Asp Ser Tyr Glu
Asp Thr Asp Tyr
Asp Thr Phe Met
Asp Thr Met Phe
Asp Thr Tyr Asp
Asp Tyr Cys Ile
Asp Tyr Cys Leu
Asp Tyr Asp Thr
Asp Tyr Glu Ser
Asp Tyr Ile Cys
Asp Tyr Leu Cys
Asp Tyr Ser Glu
Asp Tyr Thr Asp
Glu Ala Met Tyr
Glu Ala Tyr Met
Glu Cys Asp Phe
Glu Cys Phe Asp
Glu Cys Val Tyr
Glu Cys Tyr Val
Glu Asp Cys Phe
Glu Asp Phe Cys
Glu Asp Ser Tyr
Glu Asp Tyr Ser
Glu Phe Cys Asp
Glu Phe Asp Cys
Glu Phe Met Ser
Glu Phe Ser Met
Glu His Met Pro
Glu His Asn Asn
Glu His Pro Met
Glu Met Ala Tyr
Glu Met Phe Ser
Glu Met His Pro
Glu Met Pro His
Glu Met Ser Phe
Glu Met Tyr Ala
Glu Asn His Asn
Glu Asn Asn His
Glu Pro His Met
Glu Pro Met His
Glu Ser Asp Tyr
Glu Ser Phe Met
Glu Ser Met Phe
Glu Val Cys Tyr
Glu Val Tyr Cys
Glu Tyr Ala Met
Glu Tyr Cys Val
Glu Tyr Asp Ser
Glu Tyr Met Ala
Glu Tyr Ser Asp
Glu Tyr Val Cys
Phe Cys Asp Glu
Phe Cys Glu Asp
Phe Asp Cys Glu
Phe Asp Glu Cys
Phe Asp Met Thr
Phe Asp Thr Met
Phe Glu Cys Asp
Phe Glu Met Ser
Phe Glu Ser Met
Phe Met Asp Thr
Phe Met Glu Ser
Phe Met Ser Glu
Phe Met Thr Asp
Phe Ser Glu Met
Phe Ser Met Glu
Phe Thr Asp Met
Phe Thr Met Asp
His Asp Asn Gln
His Asp Gln Asn
His Glu Met Pro
His Glu Asn Asn
His Glu Pro Met
His Met Glu Pro
His Met Pro Glu
His Asn Asp Gln
His Asn Glu Asn
His Asn Asn Glu
His Asn Gln Asp
His Pro Glu Met
His Pro Met Glu
His Gln Asp Asn
His Gln Asn Asp
Ile Cys Asp Tyr
Ile Cys Tyr Asp
Ile Asp Cys Tyr
Ile Asp Tyr Cys
Ile Tyr Cys Asp
Ile Tyr Asp Cys
Leu Cys Asp Tyr
Leu Cys Tyr Asp
Leu Asp Cys Tyr
Leu Asp Tyr Cys
Leu Tyr Cys Asp
Leu Tyr Asp Cys
Met Ala Glu Tyr
Met Ala Tyr Glu
Met Cys Pro Tyr
Met Cys Tyr Pro
Met Asp Phe Thr
Met Asp Thr Phe
Met Glu Ala Tyr
Met Glu Phe Ser
Met Glu His Pro
Met Glu Pro His
Met Glu Ser Phe
Met Glu Tyr Ala
Met Phe Asp Thr
Met Phe Glu Ser
Met Phe Ser Glu
Met Phe Thr Asp
Met His Glu Pro
Met His Pro Glu
Met Met Met Thr
Met Met Thr Met
Met Pro Cys Tyr
Met Pro Glu His
Met Pro His Glu
Met Pro Tyr Cys
Met Ser Glu Phe
Met Ser Phe Glu
Met Thr Asp Phe
Met Thr Phe Asp
Met Thr Met Met
Met Tyr Ala Glu
Met Tyr Cys Pro
Met Tyr Glu Ala
Met Tyr Pro Cys
Asn Cys Asn Tyr
Asn Cys Tyr Asn
Asn Asp His Gln
Asn Asp Gln His
Asn Glu His Asn
Asn Glu Asn His
Asn His Asp Gln
Asn His Glu Asn
Asn His Asn Glu
Asn His Gln Asp
Asn Asn Cys Tyr
Asn Asn Glu His
Asn Asn His Glu
Asn Asn Tyr Cys
Asn Gln Asp His
Asn Gln His Asp
Asn Tyr Cys Asn
Asn Tyr Asn Cys
Pro Cys Met Tyr
Pro Cys Tyr Met
Pro Glu His Met
Pro Glu Met His
Pro His Glu Met
Pro His Met Glu
Pro Met Cys Tyr
Pro Met Glu His
Pro Met His Glu
Pro Met Tyr Cys
Pro Tyr Cys Met
Pro Tyr Met Cys
Gln Asp His Asn
Gln Asp Asn His
Gln His Asp Asn
Gln His Asn Asp
Gln Asn Asp His
Gln Asn His Asp
Ser Asp Glu Tyr
Ser Asp Tyr Glu
Ser Glu Asp Tyr
Ser Glu Phe Met
Ser Glu Met Phe
Ser Glu Tyr Asp
Ser Phe Glu Met
Ser Phe Met Glu
Ser Met Glu Phe
Ser Met Phe Glu
Thr Asp Asp Tyr
Thr Asp Phe Met
Thr Asp Met Phe
Thr Asp Tyr Asp
Thr Phe Asp Met
Thr Phe Met Asp
Thr Met Asp Phe
Thr Met Phe Asp
Thr Met Met Met
Thr Tyr Asp Asp
Val Cys Glu Tyr
Val Cys Tyr Glu
Val Glu Cys Tyr
Val Glu Tyr Cys
Val Tyr Cys Glu
Val Tyr Glu Cys
Tyr Ala Glu Met
Tyr Ala Met Glu
Tyr Cys Asp Ile
Tyr Cys Asp Leu
Tyr Cys Glu Val
Tyr Cys Ile Asp
Tyr Cys Leu Asp
Tyr Cys Met Pro
Tyr Cys Asn Asn
Tyr Cys Pro Met
Tyr Cys Val Glu
Tyr Asp Cys Ile
Tyr Asp Cys Leu
Tyr Asp Asp Thr
Tyr Asp Glu Ser
Tyr Asp Ile Cys
Tyr Asp Leu Cys
Tyr Asp Ser Glu
Tyr Asp Thr Asp
Tyr Glu Ala Met
Tyr Glu Cys Val
Tyr Glu Asp Ser
Tyr Glu Met Ala
Tyr Glu Ser Asp
Tyr Glu Val Cys
Tyr Ile Cys Asp
Tyr Ile Asp Cys
Tyr Leu Cys Asp
Tyr Leu Asp Cys
Tyr Met Ala Glu
Tyr Met Cys Pro
Tyr Met Glu Ala
Tyr Met Pro Cys
Tyr Asn Cys Asn
Tyr Asn Asn Cys
Tyr Pro Cys Met
Tyr Pro Met Cys
Tyr Ser Asp Glu
Tyr Ser Glu Asp
Tyr Thr Asp Asp
Tyr Val Cys Glu
Tyr Val Glu Cys
10S,11R-epoxy-punaglandin 3
6,6-Dimethylpyraono[2,3:7,8]kaempferol 4-methyl ether 3-rhamnoside
Physalin M
ST 26:8;O7
1,1-diethyl-3,3,3,3-tetramethylindocarbocyanine iodide
α-D-Galactopyranose, 2-(acetylamino)-6-O-(N-acetyl-β-neuraminosyl)-2-deoxy
Nalfurafine hydrochloride
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
Taladegib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
(4bS,6aS,7S,9aS,9bS)-N-[2,5-Bis(trifluoromethyl)phenyl]-6a-methyl-2-oxo-2,4b,5,6,6a,7,8,9,9a,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine
Talmapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
N-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]-6-sulfanylidene-5H-benzimidazolo[1,2-c]quinazoline-3-carboxamide
3-ethenyl-4-(9H-pyrido[3,4-b]indol-1-ylmethyl)-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
19-Ethenyl-18-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-2(11),4,6,8,15-pentaene-10,14-dione
[(2R,3S,4S)-5-[4-[[(1R)-1-[(7S)-2-amino-7-methyl-4-oxo-7,8-dihydro-3H-pteridin-6-yl]ethyl]amino]phenyl]-2,3,4-trihydroxypentyl] dihydrogen phosphate
alvaradoin G
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
4-(10-Methyl-8-phenyl-6-phenylamino-8,11-dihydro-5,7,8,9,11a-pentaaza-cyclopenta[b]phenanthren-11-yl)-benzene-1,2-diol
[4-(3-Chlorophenyl)-1-piperazinyl]-[1-[4-(2-pyridinyl)-1-piperazinyl]-4-isoquinolinyl]methanone
N-acetyl-beta-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
An amino disaccharide composed of N-acetylneuraminic acid and N-acetyl-alpha-D-galactosamine residues linked (2->6).
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-D-galacto-hexopyranose
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
3,4,5-trihydroxy-6-[5-methoxy-2,2-dimethyl-6-[(E)-3-oxo-3-phenylprop-1-enyl]chromen-7-yl]oxyoxane-2-carboxylic acid
[(2->6)-alpha-D-glucosyl-(1->4)-N,O(9)-diacetyl-alpha-D-neuraminosyl]n
(2S,4S,5R,6R)-5-Acetamido-2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[4-[(E)-3-(5-methoxy-2,2-dimethylchromen-6-yl)prop-2-enoyl]phenoxy]oxane-2-carboxylic acid
[(2->6)-alpha-D-glucosyl-(1->4)-N,O(7)-diacetyl-alpha-D-neuraminosyl]n
(2S,3R,4R)-3-ethenyl-4-(9H-pyrido[3,4-b]indol-1-ylmethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
An amino disaccharide composed of N-acetylneuraminic acid and 2-(acetylamino)-2-deoxy-alpha-D-galactopyranose residues in (alpha-2->6) linkage.
(1r)-2-[(3r)-3-acetyl-2,2-dimethyl-6-oxopyran-3-yl]-1-[(1r,3s,6s,7s,11s)-6-(furan-3-yl)-7,11-dimethyl-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-11-yl]ethyl acetate
methyl 5'-(furan-3-carbonyl)-1',5',8'-trimethyl-5,9'-dioxo-3a-(prop-1-en-2-yl)-6,6a-dihydro-3h-10',11'-dioxaspiro[furo[3,2-b]furan-2,7'-tricyclo[4.4.1.0²,⁸]undecan]-3'-ene-6'-carboxylate
n-[(2r,3s,6s,7r,8r)-7-(benzoyloxy)-8-ethyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
6,14-dihydroxy-10-oxo-4,12-bis(2-oxoheptyl)-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid
(1r,3s,4s,5z,7r,8r)-3-hydroxy-5-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,3-dimethyl-7-[(1e)-prop-1-en-1-yl]-8-[(5r)-2,4,5-trihydroxy-3,5-dimethyl-6-oxocyclohexa-1,3-diene-1-carbonyl]bicyclo[2.2.2]octane-2,6-dione
12-(2,3-dihydroxy-3-methylbutyl)-5,8,9-trihydroxy-7-(4-hydroxy-3-methylbut-2-en-1-yl)-2,2-dimethyl-1,11-dioxatetracen-6-one
7a,11b-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-5a,8,8,11a-tetramethyl-7,12-dihydro-6h-2,5-dioxatetraphene-1,11-dione
9,10-bis(4-hydroxy-2-methoxyphenyl)-7-methyl-8,9,9a,10-tetrahydro-5bh-1,11-dioxatetraphen-2-one
5,13,17-trihydroxy-7-(2-oxoheptyl)-17-pentyl-2,10,16-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),3(8),4,6,11,13-hexaene-9,15-dione
4,6-dihydroxy-3-[(6-hydroxy-1-oxo-3-pentylisochromen-8-yl)oxy]-2-(2-oxoheptyl)benzoic acid
11-oxo-7α-obacunyl acetate
{"Ingredient_id": "HBIN000499","Ingredient_name": "11-oxo-7\u03b1-obacunyl acetate","Alias": "NA","Ingredient_formula": "C28H32O9","Ingredient_Smile": "CC(=O)OC1CC2C(OC(=O)C=CC2(C3C1(C45C(O4)C(=O)OC(C5(CC3=O)C)C6=COC=C6)C)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16387","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-(3,4-dimethoxybenzoyl)-ajugol
{"Ingredient_id": "HBIN012580","Ingredient_name": "6-o-(3,4-dimethoxybenzoyl)-ajugol","Alias": "NA","Ingredient_formula": "C24H32O12","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC(=C(C=C4)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6204","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acuminatin ii*
{"Ingredient_id": "HBIN014650","Ingredient_name": "acuminatin ii*","Alias": "NA","Ingredient_formula": "C27H28O10","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=C(OC3=C4C=CC(OC4=CC(=C3C2=O)O)(C)C)C5=CC=C(C=C5)OC)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "593","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}